bioelectronic-medicine
(5)
Coherence Neuro
Coherence Neuro is a San Francisco medical-device company building closed-loop neurotechnology to treat cancer as a continuously monitored condition rather than a reactive battle. Founded in 2022 by University of Cambridge researchers Ben Woodington and Elise Jenkins, the company decodes the body's electrical signals in real time and delivers adaptive, AI-tuned stimulation through its flagship SOMA system - a wireless implant, wearable, and mobile app working together. Backed by a $10M seed round led by Artesian and Topology Ventures, Coherence aims to begin first-in-human trials in 2026.
NeuroBionics
NeuroBionics is a Boston-area neurotechnology company spun out of more than a decade of MIT research. It builds hair-thin, flexible bioelectronic fibers that reach neural targets through the body's blood vessels instead of open surgery. Its lead device, evStim, aims to deliver deep brain and peripheral nerve stimulation endovascularly, potentially widening access to neuromodulation therapy for conditions like Parkinson's disease, epilepsy, chronic pain, and depression.
Anuj Bhardwaj
Anuj Bhardwaj is the co-founder and CEO of SecondWave Systems, a Minneapolis-St. Paul medical device company building the SecondWave MINI, a wearable, noninvasive ultrasound device that aims to calm chronic inflammation by aiming focused sound at the spleen. He took a family-owned industrial ultrasound business founded by his parents in 1977 and redirected its core technology toward medicine, raising a $7M Series A in 2025 on top of more than $15M in government research funding from DARPA, NIH, and ARPA-H. Trained as a mechanical engineer at Penn State with an MS and MBA from MIT, he sits at the crossroads of hardware, bioelectronic medicine, and the emerging field of bio-ultrasonic therapy.
Ben Woodington
Ben Woodington is the co-founder and CEO of Coherence Neuro, a deep-tech company building SOMA-1, a button-sized, MRI-safe brain-computer interface that listens to and electrically modulates brain tumors from the inside. A Cambridge-trained chemist-turned-engineer who once built smart inhalers and minimally invasive spinal-cord interfaces, Woodington pivoted his neurotechnology to oncology after realizing almost no one was applying neural-interface engineering to cancer. He argues electricity should become the fourth pillar of cancer therapy alongside surgery, drugs, and radiation, and raised a $10M seed in late 2025 to take the work toward first human trials.
SecondWave Systems, Inc.
SecondWave Systems is a Minneapolis medical device company pioneering bio-ultrasonic medicine: a noninvasive, wearable ultrasound platform that targets the spleen with low-intensity focused ultrasound to calm chronic inflammation - offering patients with conditions like rheumatoid arthritis a drug-free alternative to biologics. Founded in 2019 by Anuj Bhardwaj, Hubert Lim, and Jeff Heyman, it builds on ultrasound expertise from the family-founded Ultran Group and over $15M in non-dilutive government support from DARPA, NIH, and ARPA-H.